{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:26:19Z","timestamp":1760297179304},"reference-count":61,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[1992,8,1]],"date-time":"1992-08-01T00:00:00Z","timestamp":712627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[1992,8]]},"DOI":"10.1016\/0002-9149(92)91081-e","type":"journal-article","created":{"date-parts":[[2004,4,28]],"date-time":"2004-04-28T17:56:15Z","timestamp":1083174975000},"page":"A66-A74","source":"Crossref","is-referenced-by-count":6,"title":["Pharmacologic treatment of supraventricular tachycardia: The German experience"],"prefix":"10.1016","volume":"70","author":[{"given":"Berndt","family":"L\u00fcderitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Manz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/0002-9149(92)91081-E_BIB1","series-title":"Cardiac arrhythmias","first-page":"449","article-title":"Classification of antiarrhythmic drugs","author":"Vaughan Williams","year":"1970"},{"key":"10.1016\/0002-9149(92)91081-E_BIB2","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0002-9149(85)91017-3","article-title":"Usefulness of programmed stimulation in predicting efficacy of propafenone in long-term antiarrhythmic therapy for paroxysmal supraventricular tachycardia","volume":"56","author":"Manz","year":"1985","journal-title":"Am J Cardiol"},{"key":"10.1016\/0002-9149(92)91081-E_BIB3","first-page":"757","article-title":"Electrophysiologic effects of diprafenone in supraventricular and ventricular tachycardia","volume":"75","author":"Manz","year":"1986","journal-title":"Z Kardiol"},{"key":"10.1016\/0002-9149(92)91081-E_BIB4","first-page":"415","article-title":"Use of diprafenone in chronic ventricular arrhythmias\u2014results of long-term treatment","volume":"76","author":"Heuer","year":"1987","journal-title":"Z Kardiol"},{"key":"10.1016\/0002-9149(92)91081-E_BIB5","first-page":"464","article-title":"Diprafenone a comparative study of antiarrhythmic therapy with propafenone","volume":"77","author":"Geibel","year":"1988","journal-title":"Z Kardiol"},{"key":"10.1016\/0002-9149(92)91081-E_BIB6","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1161\/01.CIR.82.4.1106","article-title":"Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials","volume":"82","author":"Coplen","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/0002-9149(92)91081-E_BIB7","first-page":"196","article-title":"Kombinierte Behandlung chronischer Vorhofrhythmusst\u00f6rungen mit Chinidin\u2014Verapamil","volume":"75","author":"G\u00fclker","year":"1980","journal-title":"Med Klin"},{"key":"10.1016\/0002-9149(92)91081-E_BIB8","first-page":"1120","article-title":"Behandlung tachykarder Rhythmusst\u00f6rungen des Herzens durch Beta-Rezeptorenblockade des Atrioventrikulargewebes","volume":"17","author":"Bender","year":"1966","journal-title":"Med Welt"},{"key":"10.1016\/0002-9149(92)91081-E_BIB9","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1161\/01.RES.35.3.413","article-title":"The effects of verapamil on the sinoatrial and atrioventricular nodes of the rabbit and the mechanism by which it arrests reentrant AV nodal tachycardia","volume":"35","author":"Wit","year":"1974","journal-title":"Circ Res"},{"key":"10.1016\/0002-9149(92)91081-E_BIB10","first-page":"1452","article-title":"The pharmacodynamics of orally taken verapamil and verapamil retard as judged by their negative dromotropic effects","volume":"25","author":"Schlepper","year":"1975","journal-title":"Arzneimittelforsch (Drug Res)"},{"key":"10.1016\/0002-9149(92)91081-E_BIB11","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/0002-9149(82)91251-6","article-title":"Verapamil and digoxin: their respective effects on atrial fibrillation and their interaction","volume":"50","author":"Klein","year":"1982","journal-title":"Am J Cardiol"},{"key":"10.1016\/0002-9149(92)91081-E_BIB12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-94-1-1","article-title":"Verapamil for control of ventricular rate in paroxysmal supraventricular tachycardia and atrial fibrillation on flutter","volume":"94","author":"Waxman","year":"1981","journal-title":"Ann Intern Med"},{"key":"10.1016\/0002-9149(92)91081-E_BIB13","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0002-9149(89)90253-1","article-title":"Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm","volume":"63","author":"Suttorp","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1016\/0002-9149(92)91081-E_BIB14","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1161\/01.CIR.62.5.996","article-title":"Effects of intravenous and chronic oral verapamil administration in patients with supraventricular tachyarrhythmias","volume":"62","author":"Rinkenberger","year":"1980","journal-title":"Circulation"},{"key":"10.1016\/0002-9149(92)91081-E_BIB15","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1136\/hrt.36.3.256","article-title":"Effects of verapamil on electrophysiologic properties of anomalous atrioventricular connections in Wolff-Parkinson-White syndrome","volume":"36","author":"Spurrell","year":"1974","journal-title":"Br Heart J"},{"key":"10.1016\/0002-9149(92)91081-E_BIB16","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1161\/01.CIR.67.2.426","article-title":"Effects of oral verapamil in patients with atrioventricular reentrant tachycardia incorporating an accessory pathway","volume":"67","author":"Wu","year":"1983","journal-title":"Circulation"},{"key":"10.1016\/0002-9149(92)91081-E_BIB17","first-page":"31","article-title":"Erh\u00f6hte antifibrillatorische Wirksamkeit von Chinidin bei Vorhofflimmern durch Verapamil","volume":"71","author":"G\u00fclker","year":"1982","journal-title":"Z Kardiol"},{"key":"10.1016\/0002-9149(92)91081-E_BIB18","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/BF00542121","article-title":"Effect of coadministration of verapamil and quinidine on serum digoxin concentration","volume":"25","author":"Doering","year":"1983","journal-title":"Eur J Clin Pharm"},{"key":"10.1016\/0002-9149(92)91081-E_BIB19","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0140-6736(91)91052-V","article-title":"Effective opposition to the negative list","volume":"338","author":"Kimbel","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/0002-9149(92)91081-E_BIB20","first-page":"1930","volume":"88","year":"1991","journal-title":"Dtsche \u00c4rztebl"},{"key":"10.1016\/0002-9149(92)91081-E_BIB21","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1161\/01.CIR.59.2.236","article-title":"Disopyramide phosphate, a new antiarrhythmic drug","volume":"59","author":"Yu","year":"1979","journal-title":"Circulation"},{"key":"10.1016\/0002-9149(92)91081-E_BIB22","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1161\/01.RES.65.6.1565","article-title":"Mechanisms of termination of reentrant atrial arrhythmias by class I and class III antiarrhythmic agents","volume":"65","author":"Spinelli","year":"1989","journal-title":"Circ Res"},{"key":"10.1016\/0002-9149(92)91081-E_BIB23","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/0002-9149(88)90123-3","article-title":"Facilitating influence of disopyramide on atrial flutter termination by overdrive pacing","volume":"61","author":"Bella","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1016\/0002-9149(92)91081-E_BIB24","first-page":"209","article-title":"Kardioversionsbehandlung von chronischem Vorhofflimmern und-flattern mit Disopyramid","volume":"6","author":"Beck","year":"1983","journal-title":"Med Klin"},{"key":"10.1016\/0002-9149(92)91081-E_BIB25","first-page":"392","article-title":"Effektivit\u00e4t einer intraven\u00f6sen Disopyramidtherapie zur Kardioversion supraventrikul\u00e4rer Tachyarrhythmien","volume":"18","author":"Rathgen","year":"1986","journal-title":"Herz\/Kreisl"},{"key":"10.1016\/0002-9149(92)91081-E_BIB26","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/oxfordjournals.eurheartj.a062498","article-title":"Disopyramide in the maintenance of sinus rhythm after electroconversion of atrial fibrillation. A placebo-controlled one-year follow-up study","volume":"9","author":"Karlson","year":"1988","journal-title":"Eur Heart J"},{"key":"10.1016\/0002-9149(92)91081-E_BIB27","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/cpt1974156551","article-title":"Disopyramide in the prevention of recurrence of atrial fibrillation after electrocardioversion","volume":"15","author":"H\u00e4rtel","year":"1974","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/0002-9149(92)91081-E_BIB28","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/clc.4960130409","article-title":"Prophylactic treatment after electrocardioversion of atrial fibrillation","volume":"13","author":"Karlson","year":"1990","journal-title":"Clin Cardiol"},{"key":"10.1016\/0002-9149(92)91081-E_BIB29","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJM198003133021106","article-title":"Congestive heart failure caused by oral disopyramide","volume":"302","author":"Podrid","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/0002-9149(92)91081-E_BIB30","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1378\/chest.74.6.624","article-title":"Disopyramide in patients with the Wolff-Parkinson-White syndrome and atrial fibrillation","volume":"74","author":"Bennett","year":"1978","journal-title":"Chest"},{"key":"10.1016\/0002-9149(92)91081-E_BIB31","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/0735-1097(89)90275-1","article-title":"Acute effect of disopyramide on atrial fibrillation in the Wolff-Parkinson-White syndrome","volume":"13","author":"Fujimura","year":"1989","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/0002-9149(92)91081-E_BIB32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0002-9149(76)90148-X","article-title":"Effect of amiodarone in the Wolff-Parkinson-White syndrome","volume":"38","author":"Wellens","year":"1976","journal-title":"Am J Cardiol"},{"key":"10.1016\/0002-9149(92)91081-E_BIB33","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0002-9149(74)90200-8","article-title":"Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochloride","volume":"34","author":"Rosenbaum","year":"1974","journal-title":"Am J Cardiol"},{"key":"10.1016\/0002-9149(92)91081-E_BIB34","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/0002-8703(83)90010-8","article-title":"Effect of amiodarone in paroxysmal supraventricular tachycardia with or without Wolff-Parkinson-White syndrome","volume":"106","author":"Wellens","year":"1983","journal-title":"Am Heart J"},{"key":"10.1016\/0002-9149(92)91081-E_BIB35","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/S0735-1097(85)80232-1","article-title":"Use of amiodarone in the treatment of persistant and paroxysmal atrial fibrillation resistant to quinidine therapy","volume":"6","author":"Horowitz","year":"1985","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/0002-9149(92)91081-E_BIB36","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0002-9149(86)90964-1","article-title":"Amiodarone for refractory atrial fibrillation","volume":"57","author":"Gold","year":"1986","journal-title":"Am J Cardiol"},{"key":"10.1016\/0002-9149(92)91081-E_BIB37","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/0002-8703(90)90248-V","article-title":"Rapid control of refractory atrial tachyarrhythmias with high-dose oral amiodarone","volume":"120","author":"Mostow","year":"1990","journal-title":"Am Heart J"},{"key":"10.1016\/0002-9149(92)91081-E_BIB38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1161\/01.CIR.67.1.45","article-title":"Side effects of long-term amiodarone therapy","volume":"67","author":"Harris","year":"1983","journal-title":"Circulation"},{"key":"10.1016\/0002-9149(92)91081-E_BIB39","first-page":"409","article-title":"Klinische Untersuchungen \u00fcber die Wirkungsweise des Rauwolfia-Alkaloids Ajmalin bei Herzrhythmusst\u00f6rungen, insbesondere der Extra-systolie","volume":"54","author":"Kleinsorge","year":"1959","journal-title":"Med Klin"},{"key":"10.1016\/0002-9149(92)91081-E_BIB40","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0002-9149(78)90018-8","article-title":"Orally administered prajmalium bitartrate in acute and chronic ventricular arrhythmias","volume":"41","author":"Bussmann","year":"1978","journal-title":"Am J Cardiol"},{"key":"10.1016\/0002-9149(92)91081-E_BIB41","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1177\/000331978303400307","article-title":"The efficacy of ajmaline in ventricular arrhythmia after failure of lidocaine therapy in the acute phase of myocardial infarction","volume":"34","author":"Grenadier","year":"1983","journal-title":"Angiology"},{"key":"10.1016\/0002-9149(92)91081-E_BIB42","doi-asserted-by":"crossref","unstructured":"Wellens HJJ, B\u00e4r FW, Dassen WRM, Brugada P, Vanagt EJ, Farr\u00e9 J. Effect of drugs in the Wolff-Parkinson-White syndrome. Am J Cardiol 46:665\u2013669.","DOI":"10.1016\/0002-9149(80)90518-4"},{"key":"10.1016\/0002-9149(92)91081-E_BIB43","series-title":"Aspekte der medikament\u00f6sen Behandlung von Herzrhythmusst\u00f6rungen","first-page":"43","article-title":"(1989) Klinische Pharmakokinetik von Klasse-I-Antiarrhythmika","author":"Mikus","year":"1989"},{"key":"10.1016\/0002-9149(92)91081-E_BIB44","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/0002-9149(81)90360-X","article-title":"Paroxysmal atrial flutter and fibrillation associated with pre-excitation syndrome: treatment with ajmaline","volume":"48","author":"Sclarovsky","year":"1981","journal-title":"Am J Cardiol"},{"key":"10.1016\/0002-9149(92)91081-E_BIB45","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1161\/01.CIR.50.1.114","article-title":"Effect of procainamide, quinidine and ajmaline in the Wolff-Parkinson-White syndrome","volume":"50","author":"Wellens","year":"1974","journal-title":"Circulation"},{"key":"10.1016\/0002-9149(92)91081-E_BIB46","first-page":"654","article-title":"Cibenzoline: Electrophysiologic effects of a new class 1 antiarrhythmic agent in patients with paroxysmal supraventricular tachycardia","volume":"78","author":"Pfitzner","year":"1989","journal-title":"Z Kardiol"},{"key":"10.1016\/0002-9149(92)91081-E_BIB47","first-page":"595","article-title":"Wirkung des neuen Klasse I-Antiarrhythmikurns Cibenzolin bei Patienten mit therapierefrakt\u00e4ren anhaltenden ventrikul\u00e4ren Tachykardien","volume":"77","author":"K\u00fchlkamp","year":"1988","journal-title":"Z Kardiol"},{"key":"10.1016\/0002-9149(92)91081-E_BIB48","first-page":"500","article-title":"Sotalol in patients with supraventricular tachycardia. Electrophysiologic results in the Wolff-Parkinson-White syndrome and AV nodal reentrant tachycardia","volume":"74","author":"Manz","year":"1985","journal-title":"Z Kardiol"},{"key":"10.1016\/0002-9149(92)91081-E_BIB49","first-page":"395","article-title":"Sotalol in patients with Wolff-Parkinson-White syndrome and AV nodal reentrant tachycardia","volume":"3","author":"Manz","year":"1985","journal-title":"New Trends Arrhythmias"},{"key":"10.1016\/0002-9149(92)91081-E_BIB50","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/clc.4960080903","article-title":"Adenosine triphosphate and adenosine: perspectives in the acute management of paroxysmal supraventricular tachycardia","volume":"8","author":"Belhassen","year":"1985","journal-title":"Clin Cardiol"},{"key":"10.1016\/0002-9149(92)91081-E_BIB51","doi-asserted-by":"crossref","first-page":"62D","DOI":"10.1016\/0002-9149(88)90511-5","article-title":"Summary of efficacy and safety of flecainide for supraventricular arrhythmias","volume":"62","author":"Anderson","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1016\/0002-9149(92)91081-E_BIB52","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0735-1097(10)80090-7","article-title":"Flecainide acetate treatment of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation: dose-response studies","volume":"17","author":"Pritchett","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/0002-9149(92)91081-E_BIB53","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0002-9149(91)90435-N","article-title":"Reversion of recent-onset atrial fibrillation to sinus rhythm by intravenous flecainide","volume":"67","author":"Donovan","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1016\/0002-9149(92)91081-E_BIB54","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0002-9149(86)90245-6","article-title":"Treatment of paroxysmal reentrant supraventricular tachycardia with flecainide acetate","volume":"58","author":"Kim","year":"1986","journal-title":"Am J Cardiol"},{"key":"10.1016\/0002-9149(92)91081-E_BIB55","doi-asserted-by":"crossref","unstructured":"The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 321\u2013406.","DOI":"10.1056\/NEJM198908103210629"},{"key":"10.1016\/0002-9149(92)91081-E_BIB56","first-page":"321","article-title":"The Cardiac Arrhythmia Suppression Trial (CAST)","author":"Ruskin","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/0002-9149(92)91081-E_BIB57","series-title":"Interventional Electrophysiology","first-page":"95","article-title":"The Cardiac Arrhythmia Suppression Trial (CAST)","author":"L\u00fcderitz","year":"1991"},{"key":"10.1016\/0002-9149(92)91081-E_BIB58","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199103213241201","article-title":"Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial","volume":"324","author":"Echt","year":"1991","journal-title":"New Engl J Med"},{"key":"10.1016\/0002-9149(92)91081-E_BIB59","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1055\/s-2008-1067903","article-title":"Treatment of paroxysmal atrial fibrillation with digoxin alone or digoxin plus antiarrhythmic drugs?","volume":"113","author":"Steinbeck","year":"1988","journal-title":"Dtsch Med Wschr"},{"key":"10.1016\/0002-9149(92)91081-E_BIB60","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00005344-198901000-00005","article-title":"Flecainide versus quinidine in the prevention of paroxysms of atrial fibrillation","volume":"1","author":"van Wijk","year":"1989","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/0002-9149(92)91081-E_BIB61","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0002-8703(89)90780-1","article-title":"Flecainide acetate in the treatment of supraventricular tachycardias: Value of programmed electrical stimulation for long-term prognosis","volume":"2","author":"van Wijk","year":"1989","journal-title":"Am Heart J"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:000291499291081E?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:000291499291081E?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T21:53:49Z","timestamp":1585778029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/000291499291081E"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,8]]},"references-count":61,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1992,8]]}},"alternative-id":["000291499291081E"],"URL":"https:\/\/doi.org\/10.1016\/0002-9149(92)91081-e","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[1992,8]]}}}